Funding for this research was provided by:
University of Texas MD Anderson Cancer Center (CA16672)
Received: 1 May 2018
Accepted: 20 June 2018
First Online: 11 July 2018
Ethics approval and consent to participate
: Approved under IRB protocol PA13–0246.
: IRB approved waiver of consent.
: Ramona Dadu is on the advisory board of BMS. MEC has received research funding from Eisai and Genentech. NLB has received research funding from Novartis and consulting fees from Eisai. Other authors have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.